Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 5.06
-6.99 %
$ 466 M
Market Cap
-4.39
P/E
MYGN - OPERATING INCOME
Operating Income MYGN - Myriad Genetics, Inc.
-257 M
LAST VALUE
-129.90%
2 YEAR CAGR
-103.46%
5 YEAR CAGR
-6.84%
10 YEAR CAGR